- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint that a Nuvaxovid (POM) web ad appeared without HCP confirmation. Panel found P3 Pharmacy could be an independently produced HCP journal…
PMCPA found Otsuka’s Jinarc training portal gave contradictory messages about enrolment being required to prescribe, and an HCP educational guide omitted a…
Six amalgamated complaints. Breaches found for a UK “think tank” meeting (uncertified promotional content; ‘cure’ implication) and LinkedIn likes/reposts (pre-authorisation promotion; public…
GSK was complained about after a senior leader mentioned “Arexvy” once in a LinkedIn video tied to FY2023 results. Panel found the…
Global advisory board in Madrid with a UK HCP was ruled not genuine. Panel found promotion of an investigational RSV vaccine and…
Complaint alleged Google searches allowed public access to Bayer “advertisements” for medicines. Panel found documents were non-promotional or appropriately gated for HCPs.…
Ex-contractor alleged GSK hospital reps duplicated/falsified CRM call records and management knew. Referee said call frequency aspect was in scope, but Panel…
Two Jazz-funded promotional/educational HCP videos for Epidyolex omitted key SPC liver contraindication and management guidance for concomitant valproate use. PMCPA found misleading…
A clinician complained that AstraZeneca’s public corporate medicines list showed incorrect/missing black triangle symbols and omitted Imjudo. The Panel found a breach…
Two anonymous Teva representatives alleged excessive call-rate targets and bonus-linked activity created indirect pressure to breach the Code. The Panel found briefing/instructions…
An anonymous representative alleged pressure to promote Aldara off-licence and raised concerns about call-rate targets and a GP letter. The Panel ruled…
Complaint about Lantus promotional materials. Panel ruled multiple presentations of comparative dosing/weight data were misleading due to context and incomplete disclosure, breaching…
A nurse alleged a sponsored symposium discussion implied an EpiPen could replace cardio-pulmonary resuscitation for IV iron reactions. The Panel could not…
A Diabetologia ad for Actos claimed no long-term cardiovascular concerns. The Panel found the claim insufficiently qualified versus the SPC and missing…
Anonymous GP alleged a representative’s hospitality, venue ownership and side businesses created conflicts/inducement concerns. AstraZeneca investigated meetings and payments. Panel raised perception…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.